Mrv0541 03311516252D 14 15 0 0 0 0 999 V2000 2.6184 -0.4559 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.3329 -0.0434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3329 0.7816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6185 1.1941 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.9040 0.7816 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.9040 -0.0434 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.6185 -1.2809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.6184 2.0191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3329 2.4316 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.0474 2.0191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3329 3.2565 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.1896 0.3691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.0474 1.1941 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.7619 2.4316 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 6 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 1 7 1 1 0 0 0 4 8 1 6 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 6 0 0 0 6 12 1 6 0 0 0 5 12 1 6 0 0 0 10 13 2 0 0 0 0 10 14 1 0 0 0 0 M END > CHEBI:85360 > L-dihydroanticapsin > An L-alanine derivative in which one of the methyl hydrogens of L-alanine is replaced by a 5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl group. > 3 > 3-[(1R,2S,5R,6S )-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-L-alanine > C9H15NO4 > 201.21970 > 201.10011 > 0 > N[C@@H](C[C@@H]1CC[C@@H](O)[C@@H]2O[C@H]12)C(O)=O > InChI=1S/C9H15NO4/c10-5(9(12)13)3-4-1-2-6(11)8-7(4)14-8/h4-8,11H,1-3,10H2,(H,12,13)/t4-,5-,6+,7+,8-/m0/s1 > YMLXTGCTHGQQKS-TXXZRHAASA-N > 27406393 > CPD-17531 > 23317005 $$$$